Regulatory Affairs and Pharmacovigilance: New and important
http://www.haney-pharma.de/wp-content/uploads/2020/01/BfArM-Oversight-1-5.png
720
1280
Dr. Jeanette Haney
http://www.haney-pharma.de/wp-content/uploads/2018/04/Logo_GmbH-300x173.png
Dr. Jeanette Haney2020-01-21 22:03:592020-04-11 11:33:51
http://www.haney-pharma.de/wp-content/uploads/2015/04/Mädchen_das_abrechnet.jpg
566
848
Dr. Jeanette Haney
http://www.haney-pharma.de/wp-content/uploads/2018/04/Logo_GmbH-300x173.png
Dr. Jeanette Haney2018-07-06 10:57:052018-07-06 13:48:41EudraVigilance fees
http://www.haney-pharma.de/wp-content/uploads/2018/07/XEVMPD.jpg
273
439
Dr. Jeanette Haney
http://www.haney-pharma.de/wp-content/uploads/2018/04/Logo_GmbH-300x173.png
Dr. Jeanette Haney2018-07-06 10:34:362018-07-06 11:15:55XEVMPD - Frequently Asked Questions
http://www.haney-pharma.de/wp-content/uploads/2018/02/Brexit.png
377
553
Dr. Jeanette Haney
http://www.haney-pharma.de/wp-content/uploads/2018/04/Logo_GmbH-300x173.png
Dr. Jeanette Haney2018-06-26 11:53:192018-07-02 15:20:00BREXIT: The six most important publications for pharmaceutical companies
http://www.haney-pharma.de/wp-content/uploads/2018/02/Fotolia_108942221_XXL.jpg
5562
11500
Christiane Fenske
http://www.haney-pharma.de/wp-content/uploads/2018/04/Logo_GmbH-300x173.png
Christiane Fenske2018-02-05 18:00:122018-07-03 14:55:07Brexit implications for pharmaceutical companies: the 8 most important points you need to deal with now5 good reasons for Dr. Haney Pharma GmbH…
Run by the owner
Personal and friendly
Environ-mentally aware
Innovative
Custom-made and customer-oriented
This post is also available in: German